inositol has been researched along with ALS - Amyotrophic Lateral Sclerosis in 5 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To analyze whether survival and disease progression in patients with ALS have changed during the past 20 years." | 1.33 | Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing? ( Appel, SH; Czaplinski, A; Simpson, EP; Yen, AA, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blicher, JU | 1 |
| Eskildsen, SF | 1 |
| Stærmose, TG | 1 |
| Møller, AT | 1 |
| Figlewski, K | 1 |
| Near, J | 1 |
| Weerasekera, A | 1 |
| Peeters, R | 1 |
| Sima, D | 1 |
| Dresselaers, T | 1 |
| Sunaert, S | 1 |
| De Vocht, J | 1 |
| Claeys, K | 1 |
| Van Huffel, S | 1 |
| Van Damme, P | 1 |
| Himmelreich, U | 1 |
| Choi, JK | 1 |
| Küstermann, E | 1 |
| Dedeoglu, A | 1 |
| Jenkins, BG | 1 |
| Carew, JD | 1 |
| Nair, G | 1 |
| Andersen, PM | 1 |
| Wuu, J | 1 |
| Gronka, S | 1 |
| Hu, X | 1 |
| Benatar, M | 1 |
| Czaplinski, A | 1 |
| Yen, AA | 1 |
| Simpson, EP | 1 |
| Appel, SH | 1 |
5 other studies available for inositol and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Short echo-time Magnetic Resonance Spectroscopy in ALS, simultaneous quantification of glutamate and GABA at 3 T.
Topics: Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Atrophy; Choline; Creatine; Disease Progression; | 2019 |
Motor cortex metabolite alterations in amyotrophic lateral sclerosis assessed in vivo using edited and non-edited magnetic resonance spectroscopy.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Disease Progression; Female; Glutathione; Humans; Image | 2019 |
Magnetic resonance spectroscopy of regional brain metabolite markers in FALS mice and the effects of dietary creatine supplementation.
Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Biomarkers; Brain; Creatine; Disease Models, | 2009 |
Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS.
Topics: Adult; Amyotrophic Lateral Sclerosis; Aspartic Acid; Case-Control Studies; Choline; Creatine; Cross- | 2011 |
Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Biomarkers; Dipeptides; Disease Progression; Female; Hum | 2006 |